THE IMPACT OF COFFEE BIOACTIVE COMPOUNDS ON OBESITY: MECHANISMS AND CLINICAL PERSPECTIVES
Abstract
Coffee is globally consumed and contains bioactive compounds such as caffeine and chlorogenic acids, which may have the potential to act on body weight mechanisms. This review will summarize the current evidence on the effects of coffee consumption on human obesity risk. Several observational studies have reported that an increase in coffee intake is associated with a decrease in BMI and waist circumference, especially in men. These changes may have been brought about by thermogenesis, fat oxidation, changes in appetite, glucose and lipid metabolism, and altered gut microbiota. However, these studies conflict with each other, possibly due to varying types of coffee, preparation methods, and population characteristics. Overall, moderate coffee intake appears to help indirectly in obesity prevention; yet, more studies assessing these effects and the mechanisms that can be involved are necessary.
Aim of study: The given sources consider the potential interaction between coffee consumption and either the development or prevention of obesity from a human-oriented perspective. Emphasis is placed on how the bioactive compounds, particularly caffeine and chlorogenic acids, affect bodily parameters linked to weight regulation and fat metabolism, while a few of these physiological effects may relate to appetite and the metabolism of gut microbiota.
Materials and methods: The review is based on a comprehensive analysis of current literature, including clinical trials and observational studies. PubMed and Google Scholar databases were consulted using keywords related to coffee, caffeine, chlorogenic acids, obesity, metabolism, appetite regulation, and gut microbiota to retrieve relevant articles.
References
Butt, M. S., & Sultan, M. T. (2011). Coffee and its consumption: Benefits and risks. Critical Reviews in Food Science and Nutrition, 51(4), 363–373. https://doi.org/10.1080/10408390903586412
Ding, M., Bhupathiraju, S. N., Satija, A., van Dam, R. M., & Hu, F. B. (2014). Long-term coffee consumption and risk of cardiovascular disease. Circulation, 129(6), 643–659. https://doi.org/10.1161/CIRCULATIONAHA.113.005925
Tajik, N., Tajik, M., Mack, I., & Enck, P. (2017). The potential effects of chlorogenic acid on health: A comprehensive review. European Journal of Nutrition, 56(7), 2215–2244. https://doi.org/10.1007/s00394-017-1379-1
Lee, K.-W., Kim, Y.-J., Kim, K., & Yoon, Y. S. (2023). Coffee intake and obesity: A meta-analysis. Nutrients, 15(20), 5031. https://doi.org/10.3390/nu15205031
Mills, C. E., Tzounis, X., Oruna-Concha, M. J., Mottram, D. S., Gibson, G. R., & Spencer, J. P. E. (2020). Effects of coffee and cocoa-based products on cardiovascular risk markers. European Journal of Nutrition, 59(3), 709–723. https://doi.org/10.1007/s00394-019-01943-4
Nehlig, A. (2018). Interindividual differences in caffeine metabolism. Pharmacological Reviews, 70(2), 384–411. https://doi.org/10.1124/pr.117.014407
Cornelis, M. C. (2015). Toward systems epidemiology of coffee and health. Current Opinion in Lipidology, 26(1), 20–29. https://doi.org/10.1097/MOL.0000000000000142
World Health Organization. (2021, June 9). Obesity and overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
Neeland, I. J., Ross, R., Després, J.-P., Matsuzawa, Y., Yamashita, S., Shai, I., & International Atherosclerosis Society. (2019). Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: A position statement. The Lancet Diabetes & Endocrinology, 7(9), 715–725. https://doi.org/10.1016/S2213-8587(19)30084-1
Hruby, A., & Hu, F. B. (2015). The epidemiology of obesity: A big picture. PharmacoEconomics, 33(7), 673–689. https://doi.org/10.1007/s40273-014-0243-x
Muscogiuri, G., Cantone, E., Cassarano, S., Tuccinardi, D., Barrea, L., Savastano, S., & Colao, A. (2019). Gut microbiota: A new path to treat obesity. International Journal of Obesity Supplements, 9(1), 10–19. https://doi.org/10.1038/s41367-019-0011-7
Kershaw, E. E., & Flier, J. S. (2004). Adipose tissue as an endocrine organ. The Journal of Clinical Endocrinology & Metabolism, 89(6), 2548–2556. https://doi.org/10.1210/jc.2004-0395
Coelho, M., Oliveira, T., & Fernandes, R. (2013). Biochemistry of adipose tissue: An endocrine organ. Archives of Medical Science, 9(2), 191–200. https://doi.org/10.5114/aoms.2013.33181
Westerterp, K. R. (2004). Diet induced thermogenesis. Nutrition & Metabolism, 1(1), 5. https://doi.org/10.1186/1743-7075-1-5
Astrup, A., Toubro, S., Cannon, S., Hein, P., Breum, L., & Madsen, J. (1990). Caffeine: A double-blind, placebo-controlled study of its thermogenic, metabolic, and cardiovascular effects in healthy volunteers. The American Journal of Clinical Nutrition, 51(5), 759–767. https://doi.org/10.1093/ajcn/51.5.759
Collado-Mateo, D., García-Ramos, A., Pérez-Castilla, A., Amaro-Gahete, F. J., & González-García, J. (2023). Does caffeine increase fat metabolism? A systematic review and meta-analysis. International Journal of Sport Nutrition and Exercise Metabolism, 33(2), 112–124. https://doi.org/10.1123/ijsnem.2022-0123
Hursel, R., & Westerterp-Plantenga, M. S. (2010). Thermogenic ingredients and body weight regulation. International Journal of Obesity, 34(4), 659–669. https://doi.org/10.1038/ijo.2009.299
Acheson, K. J., Gremaud, G., Meirim, I., Montigon, F., Krebs, Y., Fay, L. B., Gay, L. J., Schneiter, P., Schindler, C., & Tappy, L. (2004). Metabolic effects of caffeine in humans: Lipid oxidation or futile cycling? The American Journal of Clinical Nutrition, 79(1), 40–46.
Greenberg, J. A., Boozer, C. N., & Geliebter, A. (2006). Coffee, diabetes, and weight control. The American Journal of Clinical Nutrition, 84(4), 682–693.
Langin, D., & Arner, P. (2006). Importance of TNFα and neutral lipases in human adipose tissue lipolysis. Trends in Endocrinology & Metabolism, 17(8), 314–320. https://doi.org/10.1016/j.tem.2006.08.002
Dulloo, A. G., Geissler, C. A., Horton, T., Collins, A., & Miller, D. S. (1989). Normal caffeine consumption: Influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers. The American Journal of Clinical Nutrition, 49(1), 44–50. https://doi.org/10.1093/ajcn/49.1.44
Zhang, Q., Tang, L., Zhou, Y., Zhang, Z., Ren, Z., Liu, Y., & Liu, Y. (2021). Chlorogenic acid and caffeine combination attenuates adipogenesis by regulating fat metabolism and inhibiting adipocyte differentiation in 3T3-L1 cells. Journal of Food Biochemistry, 45(7), e13786. https://doi.org/10.1111/jfbc.13786
Schubert, M. M., Grant, G., Horner, K., King, B., Leveritt, M., Sabapathy, S., & Desbrow, B. (2014). Caffeine consumption around an exercise bout influences hunger and energy intake. International Journal of Sport Nutrition and Exercise Metabolism, 24(6), 644–653.
Roch, D. I., Boudry, G., & Koenig, J. (2009). Caffeine intake and appetite regulation: A randomized, double-blind, placebo-controlled trial. Appetite, 53(2), 148–153. https://doi.org/10.1016/j.appet.2009.06.002
González, S., Salazar, N., Ruiz, L., Gueimonde, M., Margolles, A., & de los Reyes-Gavilán, C. G. (2019). Coffee consumption modulates the intestinal microbiota of healthy people by increasing the abundance of Bifidobacterium spp. and decreasing Clostridium spp. populations. Food & Function, 10(12), 7893–7900. https://doi.org/10.1039/C9FO01404C
Verywell Health. (2025). Your daily coffee might be great for gut health, new study suggests. https://www.verywellhealth.com/coffee-gut-health-study-11696734
Jin, D., Zhang, Y., Chen, Y., Hu, Y., Li, X., & Zhang, Q. (2019). Chlorogenic acid alleviates obesity and modulates gut microbiota in high-fat-fed mice. Food & Function, 10(2), 716–728. https://doi.org/10.1039/C8FO01941A
Wang, Y., Liu, Y., Sidhu, A., Ma, Z., McClain, C., & Feng, W. (2023). Caffeine ameliorates the metabolic syndrome in diet-induced obese mice through regulating the gut microbiota and serum metabolism. Diabetology & Metabolic Syndrome, 15(1), 37. https://doi.org/10.1186/s13098-023-00993-3
Zhang, Y., Wang, Y., Liu, Y., Li, X., Zhang, Q., & Jin, D. (2019). Collaborative effects of chlorogenic acid and caffeine on lipid metabolism via the AMPKα–LXRα/SREBP-1c pathway in high-fat diet-induced obese mice. Food & Function, 10(4), 2061–2070. https://doi.org/10.1039/C9FO00502A
Belza, A., Frandsen, E., & Kondrup, J. (2007). Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: A placebo-controlled, double-blind 8-week intervention in obese subjects. International Journal of Obesity, 31(1), 121–130. https://doi.org/10.1038/sj.ijo.0803351
Cavalcanti, M. H., Roseira, J. P. S., Leandro, E. D. S., & Arruda, S. F. (2022). Effect of a freeze-dried coffee solution in a high-fat diet-induced obesity model in rats: Impact on inflammatory response, lipid profile, and gut microbiota. PLoS ONE, 17(1), e0262270. https://doi.org/10.1371/journal.pone.0262270
Bhandarkar, N. S., Brown, L., & Panchal, S. K. (2019). Chlorogenic acid attenuates high-carbohydrate, high-fat diet-induced cardiovascular, liver, and metabolic changes in rats. Nutrition Research, 62, 78–88. https://doi.org/10.1016/j.nutres.2018.11.002
Liu, S., Li, Y., Zhang, Y., Zhang, D., Liu, X., Wang, Y., & Jin, D. (2023). Coffee consumption prevents obesity-related comorbidities and promotes browning of white adipose tissue in high-fat diet-fed mice. Food Research International, 169, 112998. https://doi.org/10.1016/j.foodres.2023.112998
Greenberg, J. A., Boozer, C. N., & Geliebter, A. (2006). Coffee, diabetes, and weight control. The American Journal of Clinical Nutrition, 84(4), 682–693. https://doi.org/10.1093/ajcn/84.4.682
Schwingshackl, L., & Hoffmann, G. (2014). Long-term effects of coffee consumption on weight gain and body fat: A systematic review. Nutrition, Metabolism and Cardiovascular Diseases, 24(6), 569–580. https://doi.org/10.1016/j.numecd.2013.12.006
Copyright (c) 2025 Sylwia Bartolik, Iwona Górnicka, Aleksandra Pastuszek, Radosław Pastuszek, Magdalena Rosiewicz, Anita Janda, Marcin Durowicz, Karolina Bieńkowska, Jan Drzymała, Urszula Kierepka

This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.

